Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects
about
Compound Library Screening Identified Cardiac Glycoside Digitoxin as an Effective Growth Inhibitor of Gefitinib-Resistant Non-Small Cell Lung Cancer via Downregulation of α-Tubulin and Inhibition of Microtubule Formation.Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study.Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition.
P2860
Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@ast
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@en
type
label
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@ast
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@en
prefLabel
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@ast
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@en
P2093
P2860
P1476
Novel curcumin analogs to over ...... TKI-induced GI adverse effects
@en
P2093
Hsin-Yi Hung
Hui-Wen Chen
Jen-Yi Lee
Kuo-Hsiung Lee
Masuo Goto
Pan-Chyr Yang
Sheng-Chu Kuo
P2860
P304
P356
10.1016/J.BMC.2015.02.003
P407
P577
2015-02-13T00:00:00Z